Every patient deserves the trial that could save them.
I founded Damaros from inside clinical medicine, where the trial rift is not an abstraction. A patient exhausts the standard options. The trial that could help them is open somewhere they will never reach. For some, that distance is fatal.
A handful of elite centers can run complex protocols at scale. The community clinic down the road, where most patients are treated, cannot. The same patient, with the same disease and the same eligibility, gets the trial in one building and never hears of it in the other. Geography decides, not medicine.
That is not a medicine problem. It is an execution problem, and execution can be built.
The point is not better software. It is the patient who finally reaches the trial.
Damaros turns a community site into an audit-ready trial site: protocol logic compiled to executable criteria, evidence admitted with provenance, deterministic screening, human review, and Replay. The clinic keeps its patients and its care. The trial becomes runnable where the patient already is.
The same layer bolts onto major centers too. Damaros sits underneath as governed execution that is attributable and replayable. We do not replace Epic, CTMS, EDC, or eTMF. We create the execution record upstream of them.
Discovery is accelerating. Protocols are becoming more complex. Patient evidence is expanding across fragmented systems. Sites are being asked to operationalize work their software stack was never built to run. That gap becomes infrastructure.
The next clinical AI companies will not be built by wrapping models around workflows they do not understand. Regulated medicine does not adopt intelligence because it sounds powerful. It adopts systems that understand the work deeply enough to encode boundaries, provenance, human review, and replay. Clinical trials expose the failure first, so Damaros begins there: the need is immediate, the cost is counted in patients, and the workflow is already breaking.
Strip away the runtime, the agents, and the governance, and one question is left: did a patient who could have been saved ever reach the trial in time? Everything Damaros builds answers to that.
The doctrine stays constant: the model is not the system of record. Agents accelerate. Humans decide. Replay proves.